A Phase I / IIa Trial of PXS-5505, a Novel Pan-Lysyl Oxidase Inhibitor, in Advanced Myelofibrosis

PXS5505-MF-101 was a multi-center Phase I/IIa study of PXS-5505 in myelofibrosis patients which included a dose escalation phase and a cohort expansion phase.